Studies HIGH COLLAGEN Amino Boost
Studies on skin & beauty
32.9%
Reduction of wrinkles
7.7%
Increase in skin collagen density
6%
Increase skin hydration
7.1%
Reduction of redness
6%
Increase skin elasticity
13.1%
Improvement of the skin structure
5.6%
Reduction in the size of skin pores
2.6%
Lightening of the skin tone
Visible improvement in skin surface texture
Skin texture is one of the most visible markers of age and health. As collagen production decreases 4 starting around age 25 and accelerating by age 35 4 the skin begins to lose firmness, smoothness and elasticity.
Consumers actively seek products that can improve the
appearance of fine lines, roughness, and uneven surface
structure.
What the study shows:
Using 3D optical imaging, the clinical trial found a statistically significant improvement in skin surface appearance after 8 weeks of daily VeCollal use.
In contrast, the placebo group showed a slight deterioration over the same period.
Why this matters:
- 3D imaging offers objective, visual data 4 ideal for
marketing, training and investor decks. - Texture improvements deliver visible proof consumers
can recognize. - Performance on this front is core to anti-aging and beauty positioning.
+21 % improvement in skin hydration
Skin hydration is a fundamental pillar of skin health. Dryness leads to irritation, reduced elasticity, dullness, and accelerated aging.
As people age 4 especially women entering perimenopause and menopause 4 the skin’s ability to retain moisture declines. Hydration is also strongly associated with visible glow and comfort.
What the study shows:
Using a Corneometer, the researchers observed a +21% increase in skin hydration among VeCollal® users. This improvement was statistically validated and significantly higher than any change observed in the placebo group.
Why this matters:
- Hydration is one of the most requested and expected
outcomes in nutricosmetics. - The Corneometer is a gold-standard tool 4 widely accepted for clinical skin testing.
- Moisture supports barrier function, radiance, and product satisfaction.
+10.5 % increase in dermal collagen signal
The “holy grail” of any collagen supplement is not just to supplement, but to stimulate. Many products claim to support the body’s own collagen synthesis – but only a few can prove this. Measuring dermal collagen signal via ultrasound allows researchers to determine whether the body is indeed responding 4 and rebuilding.
What the study shows:
The VeCollal® group saw a +10.5% increase in dermal collagen signal, measured with DermaLab ultrasound tools.
This increase indicates enhanced extracellular matrix activity and collagen remodeling 4 a sign of true physiological effect.
Why this matters:
- It shows actual biological activity, not just surfacelevel change.
- It validates the biomimetic principle behind VeCollal: plant-based signals that activate real regeneration.
- For R&D and regulatory teams, this is core evidence of mechanism-of-action.
This finding puts VeCollal in a category of its own: not just mimicking collagen 4 but triggering it.
Studies on cellulite & connective tissue
–20,10 % net reduction in cellulite
Clinically tested support against cellulite
Smoother, firmer skin from the inside
Skin texture is one of the most visible markers of age and health. As collagen production decreases 4 starting around age 25 and accelerating by age 35 4 the skin begins to lose firmness, smoothness and elasticity.
Consumers actively seek products that can improve the appearance of fine lines, roughness, and uneven surface structure.
What the study shows:
After just 8 weeks of daily 5g VeCollal intake, participants saw a 20.10% net
reduction in cellulite appearance, measured via Antera 3D skin imaging. The placebo group, in contrast, showed no improvement 4 and in some cases, worsening of skin surface structure.
Why this matters:
- Cellulite is an emotionally charged concern 4 and a strong motivator for supplement use
- Most competing products make unsubstantiated claims.
- This trial provides hard clinical evidence of improvement in a common, visible condition.
This makes VeCollal one of the few scientifically backed oral solutions for cellulite reduction, validated by third-party instrumentation and university-level clinical research.
Etichub Results Summary – final
–20,10 % net reduction in cellulite
Studies on joint and cartilage health
VeCollal II can help alleviate joint discomforts
After taking VeCollal II sachet for 12 weeks, subjects felt their severity of the joint pain, stiffness and physical functioning were improved. The average WOMAC score of the subjects was reduced by 58.0%.
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of subjects with osteoarthritis of the knee and hip, including pain, stiffness, and physical functioning of the joints.
VeCollal can promotes chondroitin and hyaluronic acid secretion from chondrocytes
Nach der Einnahme eines VeCollal Sachets über 12 Wochen berichteten die Teilnehmenden über eine Verbesserung der Schwere von Gelenkschmerzen, Steifheit und der körperlichen Funktion. Der durchschnittliche WOMAC-Score der Probanden wurde um 58,0 % reduziert.
VeCollal can activate chondrocyte collagen gene and promote collagen secretion in cartilage.
It has been experimentally confirmed that VeCollal II can activate up to 50% of the type II collagen gene in chondrocytes and promote joint repair.
Studies on bone health
VeCollal can significantly reduce several inflammatory factors in chondrocytes
VeCollal II can reduce bone inflammatory factors.
VeCollal II can inhibit the production of nitric oxide (NO) by inflammatory macrophages, thus reducing the secretion of inflammatory substances and bone infiltration.
VeCollal inhibits the differentiation and maturation of osteoclasts
Experiments have shown that VeCollal can reduce the differentiation and maturation of osteoclasts and reduce the differentiation of mononuclear cells by 70 %.
VeCollal fördert die Differenzierung von Osteoblasten
It has been experimentally confirmed that VeCollal II can promote the differentiation of mesenchymal stem cells into osteoblasts, increasing stem cell differentiation by 30%.
Studies on bone density
VeCollal II can help reduce bone resorption
After taking VeCollal II sachet for 12 weeks, subjects felt their severity of the joint pain, stiffness and physical functioning were improved. The average WOMAC score of the subjects was reduced by 58.0%.
β-CrossLaps (CTx), degradation products of the cross-linked type I collagen telopeptide, reflect the extent of bone resorption and can also indicate the degree of damage to the bone tissue.
VeCollal II can help alleviate joint discomforts
After taking VeCollal II sachet for 12 weeks, the T-score of the subjects was significantly increased from -0.66 to -0.46, the change rate was 30.3%. The ratio of the subjects who had an effective improvement to the total participants was 77.8%.
A t-score reflects your bone mineral density (BMD) compared with the average BMD of a young, healthy adult of the same sex. T-scores can be used to diagnose osteopenia and osteoporosis.
